GlaxoSmithKline sales and marketing update

GSK disclosed that in June it launched its Cervarix HPV vaccine to prevent cervical cancer in Australia, Seretide salmeterol/fluticasone propionate to treat chronic obstructive pulmonary disease (COPD) and asthma in Japan, Arixtra fondaparinux to prevent venous thromboembolic events (VTE) in Japan and Veramyst fluticasone furoate nasal spray to treat allergy symptoms in the U.S. The company also disclosed that it launched Altabax retapamulin in May to treat impetigo in the U.S. ...